BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 22, 2016
View Archived Issues
Alectos receives orphan drug designation for MK-8719
Read More
First-in-human results for nesvacumab in patients with advanced solid tumors
Read More
US Phytotherapy demonstrates dengue virus inhibition in preliminary cell culture studies
Read More
COMP as a novel prognostic biomarker in breast cancer
Read More
FDA grants orphan drug designation to DelMar's VAL-083
Read More
Roche patents beta-secretase 1 inhibitors
Read More
Lead Discovery Siena discloses guanidine derivatives
Read More
Merck & Co. reports TrK-A inhibitors
Read More
NITD-008 and galidesivir improve survival and reduce viremia in AG129 mouse model of ZIKV infection
Read More
BioMarin's BMN-250 begins phase I/II trial, awarded European orphan drug designation for MPS IIIB
Read More
Repatha becomes available in Japan
Read More
Positive interim data from phase II trial of KRN-23 as treatment of tumor-induced osteomalacia
Read More
AbbVie and CytomX collaborate on Probody drug conjugate targeting CD71
Read More
Galapagos reports 20-week phase II results for filgotinib in Crohn's disease
Read More
Sitagliptin is not beneficial in nonalcoholic fatty liver disease study
Read More
TapImmune begins phase II trial for cancer vaccine TPIV-200
Read More
AstraZeneca to transform drug discovery and development through new integrated genomics initiative
Read More
Deutetrabenazine exhibits positive effects on tics in adolescents with Tourette syndrome
Read More
Achaogen awarded contract option by NIAID to support LpxC inhibitor research
Read More
Opthea provides update on phase I trial for OPT-302
Read More
FDA gives orphan drug designation to cannabidiol for TSC
Read More
SFARI launches SPARK autism research study
Read More
Janssen files for Japanese approval of Simponi for the treatment of ulcerative colitis
Read More
FDA grants orphan drug designation to NK-012
Read More
